Clinical images: Osseous and subcutaneous tophus
The therapeutic effect of tumor necrosis factor (TNF)inhibition is certainly well recognized from studies usinganti-TNF monoclonal antibodies and soluble TNF receptorfusion proteins. The article by Maini et al (Maini RN, Breed-veld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, et al.Therapeutic...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2001
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/27377
- Acceso en línea:
- https://doi.org/10.1002/1529-0131(199908)42:8<1783::AID-ANR37>3.0.CO;2-T
https://repository.urosario.edu.co/handle/10336/27377
- Palabra clave:
- Monoclonal antiphospholipid antibodies
- Rights
- License
- Abierto (Texto Completo)
| Summary: | The therapeutic effect of tumor necrosis factor (TNF)inhibition is certainly well recognized from studies usinganti-TNF monoclonal antibodies and soluble TNF receptorfusion proteins. The article by Maini et al (Maini RN, Breed-veld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, et al.Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factoramonoclonal antibody combined withlow-dose weekly methotrexate in rheumatoid arthritis. Arthri-tis Rheum 1998;41:1552–63.) provides further evidence thatTNF inhibition improves signs and symptoms of rheumatoidarthritis (RA). Unfortunately, some of the statements made inthe article are either invalid or not supportable. |
|---|